Generic drug maker Pliva expects €600m revenue in 2021

Croatia's largest pharmaceutical company Pliva - owned by the Israeli generic drugs giant Teva - expects a revenue in 2021 similar to that of last year, amounting to about 4.5 billion kuna (€600m), with 90 percent of the income coming from exports, state agency Hina reported on Monday, citing the company's CEO, Mihael Furjan. Pročitaj više